Td Private Client Wealth LLC Amphastar Pharmaceuticals, Inc. Transaction History
Td Private Client Wealth LLC
- $4.44 Trillion
- Q3 2025
A detailed history of Td Private Client Wealth LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 474 shares of AMPH stock, worth $11,248. This represents 0.0% of its overall portfolio holdings.
Number of Shares
474
Previous 1,695
72.04%
Holding current value
$11,248
Previous $38.9 Million
67.54%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AMPH
# of Institutions
260Shares Held
32.9MCall Options Held
18.3KPut Options Held
12.6K-
Black Rock Inc. New York, NY5.94MShares$141 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.69MShares$63.8 Million0.0% of portfolio
-
Td Asset Management Inc2.03MShares$48.3 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.63MShares$38.6 Million0.01% of portfolio
-
State Street Corp Boston, MA1.58MShares$37.4 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.16B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...